BTS
ABBV icon

BB&T Securities’s AbbVie ABBV Stock Holding History

BB&T Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-32,500
Closed -$1.67M – 983
2014
Q1 		$1.67M Buy
+32,500
New +$1.64M 0.04% 297

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BB&T Securities's ABBV Position: Q3 2019 in Review

BB&T Securities increased its AbbVie (ABBV) stake by 4.1% in Q3 2019, buying an estimated $2.6M and bringing the position to 964,037 shares worth $73M. The position accounts for 0.67% of the portfolio, ranked #29.

BB&T Securities first reported a position in ABBV in Q2 2013 and has held it in 26 quarters since. The position peaked at $88.4M in Q2 2016. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • BB&T Securities held 964,037 shares of AbbVie worth $73M as of Q3 2019.
  • BB&T Securities bought 37,957 AbbVie shares in Q3 2019, an estimated $2.6M.
  • AbbVie made up 0.67% of BB&T Securities's portfolio in Q3 2019, its #29 holding.
  • BB&T Securities first reported a position in AbbVie in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's AbbVie position peaked at $88.4M in Q2 2016.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.